Inside the World of Mass Timber

Cross-Sections brings to you bite-size conversations with host Anthony Gude, as he chats with colleagues and leaders in the construction and industrial ecosystem

 

On this episode of Cross-Sections, Host Anthony Gude talked with Ricky McLain, PE, SE, Senior Technical Director – Tall Wood WoodWorks™Wood Products Council about the projects they have going on and industrialized construction, mass timber, tall buildings, and other research and developments.

McClain talked about WoodWorks and what they do. WoodWorks provides education and free technical support related to the design, engineering, and construction of commercial and multi-family wood buildings in the U.S. A non-profit staffed with architects, structural engineers, and construction experts.

“We really have two main focuses,” McClain said. “First, and the biggest, is one-on-one project-specific assistance on project support.” The second area they focus on is education.

Currently, they are working on a symposium on May 27, which will examine how project teams respond to the challenges brought on by the pandemic, as well as provide some educational opportunities. The symposium will bring speakers for 12 micro-sessions tailored toward structural engineers, developers, contractors, sustainability consultants, and architects.

The duo dug into the mass timber projects that WoodWorks is currently working on, often used in mid-to-low-rise buildings, where they’re working on about 100 projects.

“From a cost perspective, mass timber and light frame wood don’t compete well with each other,” McClain said.

Listen to hear McClain talk about the mass timber projects they have going on in Cleveland and Milwaukee.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

 

Follow us on social media for the latest updates in B2B!

Image

Latest

Drug Discovery
Exploring Artificial Intelligence in Drug Discovery
April 19, 2025

Artificial intelligence is rapidly reshaping the drug discovery process, moving from augmenting research to actively driving innovation. As biotech companies face soaring R&D costs and long development cycles, AI promises a breakthrough: slashing drug development time by nearly half while improving accuracy in identifying promising compounds. With global pharmaceutical R&D spending projected to exceed $230…

Read More
KRAS
Pioneering Strategies to Unlocking the Potential of KRAS
April 18, 2025

Once labeled “undruggable,” KRAS has emerged as one of oncology’s most promising—yet complex—targets. With nearly 90% of pancreatic cancers and 30-40% of lung and colorectal cancers harboring KRAS mutations, the need for effective therapies is urgent. Recent FDA approvals of KRAS G12C inhibitors have signaled a new era, but the rise of resistance and diverse…

Read More
Polygon: Transforming Project Visions into Success Stories
April 18, 2025

Every successful project begins with a vision. The journey from ideation to fruition might seem daunting, but with the right toolkit and a trusted partner, your goals are within reach. This is where Polygon steps in. Tailoring solutions to match your unique needs, we ensure your projects kick start on a robust footing and…

Read More
Mentorship mindset
Mentorship Mindset Proves More Effective Than Tech in Boosting Student Motivation
April 18, 2025

The future of education is increasingly shaped not just by what students learn, but how they are supported in the process. As anxiety, disengagement, and mental health challenges continue to affect youth across the U.S., educators and researchers are asking: What truly motivates students to engage and thrive in school? Research suggests that the…

Read More